American Century Companies’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $626K | Buy |
173,791
+10,930
| +7% | +$39.3K | ﹤0.01% | 2454 |
|
|
2025
Q1 | $487K | Buy |
162,861
+17,666
| +12% | +$52.8K | ﹤0.01% | 2520 |
|
|
2024
Q4 | $486K | Buy |
145,195
+1,999
| +1% | +$6.7K | ﹤0.01% | 2518 |
|
|
2024
Q3 | $480K | Buy |
143,196
+18,027
| +14% | +$60.4K | ﹤0.01% | 2491 |
|
|
2024
Q2 | $414K | Buy |
125,169
+15,911
| +15% | +$52.7K | ﹤0.01% | 2504 |
|
|
2024
Q1 | $441K | Buy |
109,258
+30,504
| +39% | +$123K | ﹤0.01% | 2492 |
|
|
2023
Q4 | $240K | Buy |
78,754
+22,861
| +41% | +$69.7K | ﹤0.01% | 2638 |
|
|
2023
Q3 | $168K | Buy |
55,893
+21,503
| +63% | +$64.5K | ﹤0.01% | 2634 |
|
|
2023
Q2 | $129K | Buy |
34,390
+15,356
| +81% | +$57.4K | ﹤0.01% | 2630 |
|
|
2023
Q1 | $62.2K | Buy |
19,034
+1,671
| +10% | +$5.46K | ﹤0.01% | 2602 |
|
|
2022
Q4 | $83.5K | Buy |
17,363
+1,756
| +11% | +$8.45K | ﹤0.01% | 2483 |
|
|
2022
Q3 | $89K | Buy |
15,607
+2,963
| +23% | +$16.9K | ﹤0.01% | 2352 |
|
|
2022
Q2 | $90K | Sell |
12,644
-20,870
| -62% | -$149K | ﹤0.01% | 2238 |
|
|
2022
Q1 | $242K | Sell |
33,514
-25,413
| -43% | -$184K | ﹤0.01% | 2131 |
|
|
2021
Q4 | $527K | Sell |
58,927
-9,201
| -14% | -$82.3K | ﹤0.01% | 1906 |
|
|
2021
Q3 | $2.39M | Buy |
+68,128
| New | +$2.39M | ﹤0.01% | 1244 |
|